Abstract
INTRODUCTION:Parkinson's disease is a frequent neurodegenerative disorder characterized by motor and non-motor manifestations, such as dysautonomia, sleep disorders, sexual dysfunction, and psychiatric and cognitive disorders. It can be classified according to their motor phenotype in tremor-dominant (TD), postural instability/gait difficulty (DMI), and indeterminate subtypes. This study established the influence of motor phenotype on the cardiovascular dysautonomia of patients with Parkinson's disease from the neurology outpatient clinic at the IVSS hospital "Dr. Patrocinio Peñuela Ruiz," from May 2015 to April 2016.
METHODS:Observational, descriptive, cross-sectional study in patients older than 40 years with idiopathic PD. The MDS-UPDRS scale, Hoehn and Yahr scale, Scopa-AUT scale, Orthostatic Hypotension, and RINES-VALCARDI were evaluated.
RESULTS:A sample of 57 was obtained, and after applying inclusion and exclusion criteria, 37 subjects were studied. All the patients had some degree of dysautonomia (measured with SCOPA- AUT scale). The SCOPA-AUT was higher in patients with orthostatic hypotension (p= .003), finding this same difference for the cardiovascular subscale (p = .026). Both autonomic neuropathy (measured with RINES-VALCARDI) and orthostatic hypotension were found more frequently on the DMI phenotype (p= <.001 and p=.016).
CONCLUSION:Dysautonomia is frequent in PD patients; there was a difference between SCOPA-AUT total score and cardiovascular subscale according to orthostatic hypotension; those with DMI phenotype have a greater risk of orthostatic hypotension and cardiac autonomic neuropathy.
References
Toro AC, Buriticá OF. Enfermedad de Parkinson: criterios diagnósticos, factores de riesgo y de progresión, y escalas de valoración del estadio clínico. Acta Neurol Colomb. 2014;30(4):300-6.
Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015;386(9996):896-912.
Sánchez JAD, Guevara LC, Fernando L, Betancourt G, Arango AFL, Ramírez M. Descripción de la población de pacientes con enfermedad de Parkinson en un centro médico neurológico en la ciudad de Cali, Colombia. 2011;27(4):7.
Dorsey ER, Elbaz A, Nichols E, Abd-Allah F, Abdelalim A, Adsuar JC, et al. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939-53.
Saavedra Moreno JS, Millán PA, Buriticá Henao OF. Introducción, epidemiología y diagnóstico de la enfermedad de Parkinson. Acta Neurol Colomb. 2019;35(3 Supl. 1):2-10.
Lizbeth VC, Amiel TR, Rafael GPJ, Márquez M, Rebeca TCM, Porfirio CC, et al. Enfermedad de Parkinson más allá de lo motor. Neurobiología. 2019;18.
Neri-Nani GA. Síntomas motores de la enfermedad de Parkinson. Neurol Neurocir Psiquiatr. 2017;45(2):45-50.
Váradi C. Clinical features of Parkinson's disease: the evolution of critical symptoms. Biology. 2020;9(5):103.
Ariza-Serrano LM, Guerrero-Vega J, Ortiz P, Moreno-López CL. Caracterización de pacientes con enfermedad de Parkinson en un centro de referencia de la ciudad de Bogotá, Colombia. Acta Neurol Colomb. 2016;32(3):203-8.
Pagano G, Ferrara N, Brooks DJ, Pavese N. Age at onset and Parkinson disease phenotype. Neurology. 2016;86(15):1400-7.
Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale: PIGD and The MDS-UPDRS. Mov Disord. 2013;28(5):668-70.
Rodríguez-Violante M, Zerón-Martínez R, Cervantes-Arriaga A. Complejo sintomático no motor de la enfermedad de Parkinson. Neurol Neurocir Psiquiatr. 2017;45(2):51-60.
Poewe W Non-motor symptoms in Parkinson's disease. Eur J Neurol. 2008;15(s1):14-20.
Rueda Acevedo M, Castro Fuquen F. Disfunción autonómica en la enfermedad de Parkinson: enfoque práctico. Acta Neurol Colomb. 2019;35(3 Supl. 1):69-74.
Alvarado-Jalomo S. Evaluación de la presencia de disautonomía en pacientes con Parkinson mediante el análisis de señales cardiovasculares [Internet]. Rev Mex Ing Bioméd. 2016 [citado 2021, agosto 1.o]. Disponible en: Disponible en: http://www.rmib.somib.org.mx/pdfs/Vol38/No1/10%20RMIB2016-31-C.pdf
Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368-76.
Titova N, Padmakumar C, Lewis SJG, Chaudhuri KR. Parkinson's: a syndrome rather than a disease? J Neural Transm. 2017;124(8):907-14.
Sabino-Carvalho JL, Falquetto B, Takakura AC, Vianna LC. Baroreflex dysfunction in Parkinson's disease: integration of central and peripheral mechanisms. J Neurophysiol. 2021;125(4):1425-39.
Terjung R, editor. Comprehensive physiology [Internet. Wiley; 2011 [citado 2021, agosto 1.o]. Disponible en: Disponible en: https://onlineli-brary.wiley.com/doi/book/10.1002/cphy
Palma JA, Kaufmann H. Orthostatic hypotension in Parkinson disease. Clin Geriatr Med. 2020;36(1):53-67.
Suárez Moro R, Castaño García B. Trastornos cardiovasculares en la enfermedad de Parkinson. Rev Neurol. 2010;50(S02):59.
Pérez Saldaña MT, Pérez Velasco R, Burguera Hernández JA. Diagnóstico precoz y diferencial de la disautonomía en la enfermedad de Parkinson mediante gammagrafía cardíaca con 123I-MIBG. Rev Neurol. 2009;49(11):613.
Jiménez-Hoyuela García JM. Aplicaciones neurológicas de la gammagrafía de inervación miocárdica con 123-I-MIBG. Rev Esp Med Nucl. 2011;30(3):197-204.
Alvarez C. Nuevo método de evaluación diagnóstica. Arch Hosp Vargas. 1981;23:17-41.
Rengel DA, Chacín González M, Ramírez KN, Bermúdez-Pirela V. Prevalencia de neuropatía autonómica cardiovascular por el método Rines Valcardi modificado en individuos diabéticos de dos servicios de atención médica primaria. Rev Latinoam Hipertens. 2019;14(5), 624-8.
Fernández Collado C, Baptista Lucio P, Hernández Sampieri R. Metodología de la investigación. McGraw-Hill; 2014
World Medical Association (WMA). Declaración de Helsinki de la AMM - Principios éticos para las investigaciones médicas en seres humanos [Internet]. [citado 2020, marzo 29]. Disponible en: Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/
Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56(1):33.
Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745-52.
Movement disorder society task force on rating scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations. Mov Disord. 2003;18(7):738-50.
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129-70.
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality [Internet]. 1967 [citado 2020, junio 4]. Disponible en: Disponible en: /paper/Parkinsonism%3A-onset%2C-progression-and-mortality.-Hoehn-Yahr/9c505fdd165d4220d15a96c86debab59bc775dbb
Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson's disease: The Scopa-AUT. Mov Disord. 2004;19(11):1306-12.
Bradley JG, Davis KA. Orthostatic hypotension. Am Fam Physician. 15 de diciembre de 2003;68(12):2393-8.
Duncan GW, Khoo TK, Yarnall AJ, O'Brien JT, Coleman SY, Brooks DJ, et al. Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms: Quality of life in early Parkinson's disease. Mov Disord. 2014;29(2):195-202.
Hermanowicz N, Jones SA, Hauser RA. Impact of non-motor symptoms in Parkinson's disease: a PMD alliance survey. Neuropsychiatr Dis Treat. 2019; 15:2205-12.
Bostantjopoulou S, Katsarou Z, Danglis I, Karakasis H, Milioni D, Falup-Pecurariu C. Self-reported autonomic symptoms in Parkinson's disease: properties of the Scopa-AUT scale. Hippokratia. 2016;20(2):115.
Stankovic I, Petrovic I, Pekmezovic T, Markovic V, Stojkovic T, Dragasevic-Miskovic N, et al. Longitudinal assessment of autonomic dysfunction in early Parkinson's disease. Parkinsonism Relat Disord. 2019;66:74-9.
Merola A, Romagnolo A, Rosso M, Suri R, Berndt Z, Maule S, et al. Autonomic dysfunction in Parkinson's disease: A prospective cohort study: prospective PD autonomic function assessment. Mov Disord. 2018;33(3):391-7.
van der Heeden JF, Marinus J, Martinez-Martin P, Rodriguez-Blazquez C, Geraedts VJ, van Hilten JJ. Postural instability and gait are associated with severity and prognosis of Parkinson disease. Neurology. 2016;86(24):2243-50.
Rodríguez-Violante M, Cervantes-Arriaga A, García-Ibarra D, Corona T. Respuesta ortostática de la tensión arterial de pacientes con enfermedad de Parkinson inicial. Arch Cardiol México. 2013;83(2):93-9.
Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RMA. Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2011;17(10):724-9.
Allcock LM, Kenny RA, Burn DJ. Clinical phenotype of subjects with Parkinson's disease and orthostatic hypotension: Autonomic symptom and demographic comparison: PD and orthostatic hypotension. Mov Disord. 2006;21(11):1851-5.
Hiorth YH, Pedersen KF, Dalen I, Tysnes OB, Alves G. Ortho-static hypotension in Parkinson disease: A 7-year prospective population-based study. Neurology. 2019;93(16):e1526-34.
Kotagal V, Lineback C, Bohnen NI, Albin RL. Orthostatic hypotension predicts motor decline in early Parkinson disease. Parkinsonism Relat Disord. 2016;32:127-9.
Scorza FA, Fiorini AC, Scorza CA, Finsterer J. Cardiac abnormalities in Parkinson's disease and Parkinsonism. J Clin Neurosci. 2018;53:1-5.
Strano S, Fanciulli A, Rizzo M, Marinelli P, Palange P, Tiple D, et al. Cardiovascular dysfunction in untreated Parkinson's disease: A multi-modality assessment. J Neurol Sci. 2016;370:251-5.
Haapaniemi TH. Ambulatory ECG and analysis of heart rate variability in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2001;70(3):305-10.
Berganzo K, Tijero B, González-Eizaguirre A, Somme J, Lezcano E, Gabilondo I, et al. Síntomas no motores y motores en la enfermedad de Parkinson y su relación con la calidad de vida y los distintos subgrupos clínicos. Neurología. 2016;31(9):585-91.
Ba F, Obaid M, Wieler M, Camicioli R, Martin WRW. Parkinson disease: The relationship between non-motor symptoms and motor phenotype. Can J Neurol Sci J Can Sci Neurol. 2016;43(2):261-7.
Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol. 2001;58(10):1611.
Khoo TK, Yarnall AJ, Duncan GW, Coleman S, O'Brien JT, Brooks DJ, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology. 2013;80(3):276-81.
Spiegel J, Hellwig D, Farmakis G, Jost WH, Samnick S, Fass-bender K, et al. Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease. Mov Disord. 2007;22(7):1004-8.
Saiki S, Hirose G, Sakai K, Kataoka S, Hori A, Saiki M, et al. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci. 2004;220(1-2):105-11.
Espinoza-Valdés Y, Córdova-Arellano R, Espinoza-Espinoza M, Méndez-Alfaro D, Bustamante-Aguirre JP, Maureira-Pareja HA, et al. Association between cardiac autonomic control and postural control in patients with Parkinson's Disease. Int J Environ Res Public Health. 2020;18(1):249.
Sibley KM, Mochizuki G, Lakhani B, McIlroy WE. Autonomic contributions in postural control: a review of the evidence. Rev Neurosci [Internet]. 2014 [citado 2021, agosto 1.o];25(5). Disponible en: Disponible en: https://www.degruyter.com/document/doi/10.1515/revneuro-2014-0011/html
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.